InsiderTrades

Form 4 for AUPH Aurinia Pharmaceuticals Inc.

Accepted 2023-05-23 00:00:00 ET · period of report 2023-05-18 · accession 0001600620-23-000022 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-05-23 2023-05-18 AUPH Jayne David R.W. Dir M - OptEx — +8,733 48.7K +22% —
D 2023-05-23 2023-05-23 AUPH Jayne David R.W. Dir S - Sale+OE $11.26 -8,733 49.3K -15% -$98.3K
D 2023-05-23 2023-05-19 AUPH Jayne David R.W. Dir A - Grant $0.00 +9,310 58.0K +19% $0
D 2023-05-23 2023-05-19 AUPH Jayne David R.W. Dir A - Grant $0.00 +15.2K 15.2K New $0
D 2023-05-23 2023-05-18 AUPH Jayne David R.W. Dir M - OptEx $0.00 -8,733 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-05-18 M A 8,733 — 48,733 D — — (F1) Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of Issuer Common Stock. The RSUs have no expiration date.
2 Common Common Stock 2023-05-23 S D 8,733 $11.26 49,310 D — —
3 Common Common Stock 2023-05-19 A A 9,310 $0.00 58,043 D — — (F2) Represents grant of the RSUs payable solely in common stock of the Issuer. The shares subject to the RSUs shall vest one year from date of grant.
4 Derivative Stock Option (right to buy) 2023-05-19 A A 15,234 $0.00 15,234 D $10.74 · — to 2033-05-19 15,234 Common Stock (F3) The option vests in twelve equal monthly installments commencing on June 19, 2023.
5 Derivative Restricted Stock Units 2023-05-18 M D 8,733 $0.00 0 D — · 2023-05-18 to — 8,733 Common Stock (F1) Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of Issuer Common Stock. The RSUs have no expiration date.